{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T20:58:06Z","timestamp":1782766686299,"version":"3.54.5"},"reference-count":47,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2010,7,7]],"date-time":"2010-07-07T00:00:00Z","timestamp":1278460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Internal Medicine"],"published-print":{"date-parts":[[2010,10]]},"abstract":"<jats:p><jats:bold>Abstract.\u2002<\/jats:bold>Ebbing M., B\u00f8naa K.H., Arnesen E., Ueland P.M., Nordrehaug J.E., Rasmussen K., Nj\u00f8lstad I., Nilsen D.W., Refsum H., Tverdal A., Vollset S.E., Schirmer H., Bleie \u00d8., Steigen T., Midttun \u00d8., Fredriksen \u00c5., Pedersen E.R., Nyg\u00e5rd O. (From the Departments of<jats:sup>1<\/jats:sup>Heart Disease, Haukeland University Hospital, Bergen; Heart Disease, University Hospital of North Norway; Department of Community Medicine, University of Troms\u00f8, Troms\u00f8; Institute of Medicine, University of Bergen, Bergen; Department of Clinical Medicine, University of Troms\u00f8, Troms\u00f8; Department of Cardiology, Stavanger University Hospital, Stavanger; Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway; Department of Physiology, Anatomy &amp; Genetics, University of Oxford, Oxford, UK; Division of Epidemiology, the Norwegian Institute of Public Health, Oslo; Department of Public Health and Primary Health Care, University of Bergen; Bevital AS, Bergen; Norway) Combined Analyses and Extended Follow\u2010Up of Two Randomized Controlled Homocysteine\u2010Lowering B\u2010Vitamin Trials.<jats:italic>J Intern Med<\/jats:italic>2010;<jats:bold>268<\/jats:bold>: 367\u2013382.<\/jats:p><jats:p><jats:bold>Objectives.\u2002<\/jats:bold>In the Norwegian Vitamin Trial and the Western Norway B Vitamin Intervention Trial, patients were randomly assigned to homocysteine\u2010lowering B\u2010vitamins or no such treatment. We investigated their effects on cardiovascular outcomes in the trial populations combined, during the trials and during an extended follow\u2010up, and performed exploratory analyses to determine the usefulness of homocysteine as a predictor of cardiovascular outcomes.<\/jats:p><jats:p><jats:bold>Design.\u2002<\/jats:bold>Pooling of data from two randomized controlled trials (1998\u20132005) with extended post\u2010trial observational follow\u2010up until 1 January 2008.<\/jats:p><jats:p><jats:bold>Setting.\u2002<\/jats:bold>Thirty\u2010six hospitals in Norway.<\/jats:p><jats:p><jats:bold>Subjects.\u2002<\/jats:bold>6837 patients with ischaemic heart disease.<\/jats:p><jats:p><jats:bold>Interventions.\u2002<\/jats:bold>One capsule per day containing folic acid (0.8\u2003mg) plus vitamin B12 (0.4\u2003mg) and vitamin B6 (40\u2003mg), or folic acid plus vitamin B12, or vitamin B6 alone or placebo.<\/jats:p><jats:p><jats:bold>Main outcome measures.\u2002<\/jats:bold>Major adverse cardiovascular events (MACEs; cardiovascular death, acute myocardial infarction or stroke) during the trials and cardiovascular mortality during the extended follow\u2010up.<\/jats:p><jats:p><jats:bold>Results.\u2002<\/jats:bold>Folic acid plus vitamin B12 treatment lowered homocysteine levels by 25% but did not influence MACE incidence (hazard ratio, 1.07; 95% CI, 0.95\u20131.21) during 39\u2003months of follow\u2010up, or cardiovascular mortality (hazard ratio, 1.12; 95% CI, 0.95\u20131.31) during 78\u2003months of follow\u2010up, when compared to no such treatment. Baseline homocysteine level was not independently associated with study outcomes. However, homocysteine concentration measured after 1\u20132\u2003months of folic acid plus vitamin B12 treatment was a strong predictor of MACEs.<\/jats:p><jats:p><jats:bold>Conclusion.\u2002<\/jats:bold>We found no short\u2010 or long\u2010term benefit of folic acid plus vitamin B12 on cardiovascular outcomes in patients with ischaemic heart disease. Our data suggest that cardiovascular risk prediction by plasma total homocysteine concentration may be confined to the homocysteine fraction that does not respond to B\u2010vitamins.<\/jats:p>","DOI":"10.1111\/j.1365-2796.2010.02259.x","type":"journal-article","created":{"date-parts":[[2010,7,7]],"date-time":"2010-07-07T20:31:58Z","timestamp":1278534718000},"page":"367-382","source":"Crossref","is-referenced-by-count":63,"title":["Combined analyses and extended follow\u2010up of two randomized controlled homocysteine\u2010lowering B\u2010vitamin trials"],"prefix":"10.1111","volume":"268","author":[{"given":"M.","family":"Ebbing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. H.","family":"B\u00f8naa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Arnesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. M.","family":"Ueland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. E.","family":"Nordrehaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Nj\u00f8lstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. W.","family":"Nilsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Refsum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tverdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. E.","family":"Vollset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Schirmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8.","family":"Bleie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Steigen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8.","family":"Midttun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5.","family":"Fredriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. R.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Nyg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,9]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.49.1.31"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/24.4.704"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199707243370403"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/67.2.263"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-131-5-199909070-00003"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.10.2825"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.5.437"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.5.359"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2007.346"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03530130055028"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.8.936"},{"key":"e_1_2_9_13_2","first-page":"8","article-title":"Trends in wheat\u2010flour fortification with folic acid and iron \u2013 worldwide, 2004 and 2007","volume":"57","author":"Centers for Disease Control and Prevention","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa060900"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.299.17.2027"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.5.565"},{"issue":"2","key":"e_1_2_9_17_2","first-page":"741","article-title":"Blinded comparison of folic acid and placebo in patients with ichemic heart disease: an outcome trial","volume":"106","author":"Baker F","year":"2002","journal-title":"Circulation"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055227"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.300.7.795"},{"key":"e_1_2_9_20_2","first-page":"2310","article-title":"SEARCH (Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine): randomized comparison of folic acid 2\u2003mg plus vitamin B12 1\u2003mg daily versus placebo for 7\u2003years in 12,064 myocardial infarction survivors","volume":"118","author":"Armitage J","year":"2008","journal-title":"Circulation"},{"key":"e_1_2_9_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.10.1163"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/01434893-200509000-00011"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006612.pub2"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.16.2023"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.325.7374.1202"},{"key":"e_1_2_9_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.44.7.592"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.45.4.344"},{"key":"e_1_2_9_28_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2005.053835"},{"key":"e_1_2_9_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.4013"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2008.115378"},{"key":"e_1_2_9_31_2","unstructured":"Statistics Norway.Causes of deaths 2007. Statistics Norway (Statistisk sentralbyr\u00e5);2009(cited 2010 January 18); Available from:http:\/\/www.ssb.no\/dodsarsak_en\/."},{"key":"e_1_2_9_32_2","first-page":"197","volume-title":"An Introduction to Survival Analysis Using Stata","author":"Cleves M","year":"2008"},{"key":"e_1_2_9_33_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2003.021634"},{"key":"e_1_2_9_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.11.1227"},{"key":"e_1_2_9_35_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.12.1834"},{"key":"e_1_2_9_36_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.6.605"},{"key":"e_1_2_9_37_2","doi-asserted-by":"publisher","DOI":"10.4065\/83.11.1203"},{"key":"e_1_2_9_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2009.02077.x"},{"key":"e_1_2_9_39_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38611.658947.55"},{"key":"e_1_2_9_40_2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1373\/clinchem.2006.083881","article-title":"Homocysteine, 5,10\u2010methylenetetrahydrofolate reductase 677C>T polymorphism, nutrient intake, and incident cardiovascular disease in 24,968 initially healthy women","volume":"53","author":"Zee RY","year":"2007","journal-title":"Clin Chem"},{"key":"e_1_2_9_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20522"},{"key":"e_1_2_9_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12012-009-9042-6"},{"key":"e_1_2_9_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/136.6.1731S"},{"key":"e_1_2_9_44_2","doi-asserted-by":"publisher","DOI":"10.1159\/000142725"},{"key":"e_1_2_9_45_2","doi-asserted-by":"publisher","DOI":"10.2174\/157016106777698379"},{"key":"e_1_2_9_46_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.60.041807.123308"},{"key":"e_1_2_9_47_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1622"},{"key":"e_1_2_9_48_2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/ajcn\/86.1.214","article-title":"Plasma pyridoxal\u20105\u2010phosphate and future risk of myocardial infarction in the European Prospective Investigation into Cancer and Nutrition Potsdam cohort","volume":"86","author":"Dierkes J","year":"2007","journal-title":"Am J Clin Nutr"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2796.2010.02259.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2796.2010.02259.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T19:17:58Z","timestamp":1740251878000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2796.2010.02259.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["10.1111\/j.1365-2796.2010.02259.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2796.2010.02259.x","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}